161 related articles for article (PubMed ID: 36795185)
1. TRAF4 Silencing Induces Cell Apoptosis and Improves Retinoic Acid Sensitivity in Human Neuroblastoma.
Gu Y; Zhong K; Peng L; Ding W; Zeng X
Neurochem Res; 2023 Jul; 48(7):2116-2128. PubMed ID: 36795185
[TBL] [Abstract][Full Text] [Related]
2. TRAF inhibition drives cancer cell apoptosis and improves retinoic acid sensitivity in multiple cancers models.
Zhong K; Liu X; Ding W; Peng L; Zeng X; Gu Y
Discov Oncol; 2023 Jun; 14(1):117. PubMed ID: 37389738
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of silenced α-N-catenin induces retinoic acid sensitivity in neuroblastoma cells.
Clark RA; Newton M; Qiao J; Lee S; Chung DH
Surgery; 2021 Nov; 170(5):1546-1553. PubMed ID: 34092372
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces the differentiation of retinoic acid-resistant neuroblastoma cells via upregulation of HoxC9.
Li C; Feng C; Chen Y; Wu P; Li P; Xiong X; Peng X; Wang Z; Li Y
Adv Clin Exp Med; 2022 Aug; 31(8):903-911. PubMed ID: 35467087
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Properties of Platinum Nanoparticles and Retinoic Acid: Combination Therapy for the Treatment of Human Neuroblastoma Cancer.
Gurunathan S; Jeyaraj M; Kang MH; Kim JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947930
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
Joshi S; Guleria R; Pan J; DiPette D; Singh US
Oncogene; 2006 Jan; 25(2):240-7. PubMed ID: 16158052
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout.
Lovat PE; Irving H; Annicchiarico-Petruzzelli M; Bernassola F; Malcolm AJ; Pearson AD; Melino G; Redfern CP
J Natl Cancer Inst; 1997 Mar; 89(6):446-52. PubMed ID: 9091647
[TBL] [Abstract][Full Text] [Related]
8. Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
Hossain MM; Banik NL; Ray SK
Exp Cell Res; 2012 Aug; 318(13):1597-610. PubMed ID: 22507272
[TBL] [Abstract][Full Text] [Related]
9. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.
Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ
Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808
[TBL] [Abstract][Full Text] [Related]
10. Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation.
Shelake S; Eslin D; Sutphin RM; Sankpal UT; Wadwani A; Kenyon LE; Tabor-Simecka L; Bowman WP; Vishwanatha JK; Basha R
Int J Dev Neurosci; 2015 Nov; 46():92-9. PubMed ID: 26287661
[TBL] [Abstract][Full Text] [Related]
11. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid reduces human neuroblastoma cell migration and invasiveness: effects on DCX, LIS1, neurofilaments-68 and vimentin expression.
Messi E; Florian MC; Caccia C; Zanisi M; Maggi R
BMC Cancer; 2008 Jan; 8():30. PubMed ID: 18230156
[TBL] [Abstract][Full Text] [Related]
13. Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells.
Veal GJ; Errington J; Redfern CP; Pearson AD; Boddy AV
Biochem Pharmacol; 2002 Jan; 63(2):207-15. PubMed ID: 11841795
[TBL] [Abstract][Full Text] [Related]
14. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells.
Voigt A; Zintl F
Med Pediatr Oncol; 2003 Apr; 40(4):205-13. PubMed ID: 12555246
[TBL] [Abstract][Full Text] [Related]
15. Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide.
Reynolds CP; Wang Y; Melton LJ; Einhorn PA; Slamon DJ; Maurer BJ
Med Pediatr Oncol; 2000 Dec; 35(6):597-602. PubMed ID: 11107126
[TBL] [Abstract][Full Text] [Related]
16. Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid.
Lovat PE; Irving H; Annicchiarico-Petruzzelli M; Bernassola F; Malcolm AJ; Pearson AD; Melino G; Redfern CP
Eur J Cancer; 1997 Oct; 33(12):2075-80. PubMed ID: 9516856
[TBL] [Abstract][Full Text] [Related]
17. SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization.
Yi P; Xia W; Wu RC; Lonard DM; Hung MC; O'Malley BW
Genes Dev; 2013 Feb; 27(3):274-87. PubMed ID: 23388826
[TBL] [Abstract][Full Text] [Related]
18. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.
Ora I; Bondesson L; Jönsson C; Ljungberg J; Pörn-Ares I; Garwicz S; Pâhlman S
Biochem Biophys Res Commun; 2000 Oct; 277(1):179-85. PubMed ID: 11027660
[TBL] [Abstract][Full Text] [Related]
20. High expression of TRAF4 predicts poor prognosis in tamoxifen-treated breast cancer and promotes tamoxifen resistance.
Zhou J; Li W; Ming J; Yang W; Lu L; Zhang Q; Ruan S; Huang T
Anticancer Drugs; 2020 Jul; 31(6):558-566. PubMed ID: 32304412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
